Cite
MLA Citation
A. Marshall et al.. “PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial.” Thrombosis research, no. 200, n.d., pp. S36–. http://access.bl.uk/ark:/81055/vdc_100129510609.0x00004f